scispace - formally typeset
S

Suzanne Oparil

Researcher at University of Alabama at Birmingham

Publications -  941
Citations -  122414

Suzanne Oparil is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Blood pressure & Angiotensin II. The author has an hindex of 106, co-authored 885 publications receiving 113983 citations. Previous affiliations of Suzanne Oparil include Michigan State University & Oregon Health & Science University.

Papers
More filters
Journal ArticleDOI

Assessment of vascular function in low socioeconomic status preschool children: a pilot study.

TL;DR: Noninvasive assessment of central BP and arterial stiffness is feasible in preschool children and vascular inflammation may be an important factor that influences BP at an early age to elucidate mechanisms of early onset hypertension.
Journal ArticleDOI

Enhanced cold pressor response in spontaneously hypertensive rats on high-NaCl diet.

TL;DR: OH rats on a high-NaCl diet have an enhanced pressor response to acute cold exposure compared with SHR on a normal NaCl diet, and the AVP V1 antagonist completely abolished the cold stress-induced rise in MAP in SHR.
Journal ArticleDOI

Enhanced depressor effect of bromocriptine in the DOCA/NaCl hypertensive rat.

TL;DR: The hyperprolactinemia and enhanced depressor response to bromocriptine observed in DOCA/NaCl animals suggest that the dopaminergic system might be altered in this model of hypertension.
Journal ArticleDOI

Enhanced depressor effect of muscimol in the DOCA/NaCl hypertensive rat: evidence for altered GABAergic activity in brain.

TL;DR: The results suggest that the activity of the central GABAergic system is altered in the rat with established DOCA/NaCl hypertension and that the alteration incentral GABAergic function may be related to the increased sympathoadrenal activity and the maintenance of hypertension in this model.

COMMENTARY Hypertension in Women

TL;DR: A review of hypertension with emphasis on male gender finds that there are unique issues with respect to the epidemiology, risk, and treatment of hypertension in men, which will be discussed in this review.